original ) (raw )Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine
Pietro Lo Giudice
Clinical cancer research : an official journal of the American Association for Cancer Research, 2003
View PDFchevron_right
A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy
Adolfo De Pasquale Ceratti , Sante Cundari
Tumori
View PDFchevron_right
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitine
Sante Cundari
European Journal of Cancer, 2005
View PDFchevron_right
A prospective study to evaluate the efficacy and safety of oral acetyl‑L‑carnitine for the treatment of chemotherapy‑induced peripheral neuropathy
Yang Yu yao
Experimental and Therapeutic Medicine, 2016
View PDFchevron_right
Amelioration of Oxaliplatin Neurotoxicity by Drugs in Humans and Experimental Animals: A MiniReview of Recent Literature
Badreldin Ali
Basic & Clinical Pharmacology & Toxicology, 2009
View PDFchevron_right
Neuroprotective Propensity of 4-Allylpyrocatechol Derivatives against Oxaliplatin Induced Peripheral Neuropathy
vijay kotra
2021
View PDFchevron_right
Role of Alpha Lipoic Acid in Prevention of Oxaliplatin Neurological Toxicity
Nehal Elmashad
Life Science Journal, 2013
View PDFchevron_right
Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine
Sante Cundari
In vivo (Athens, Greece)
View PDFchevron_right
Protective effect of acetyl-l-carnitine on the apoptotic pathway of peripheral neuropathy
Menotti Calvani
European Journal of Neuroscience, 2007
View PDFchevron_right
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat
Paola Marmiroli
European Journal of Cancer, 2001
View PDFchevron_right
Protective actions of l-carnitine and acetyl-l-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors
Menotti Calvani
Pharmacological Research, 1995
View PDFchevron_right
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
LAURA BOSSI
Seminars in Oncology, 2002
View PDFchevron_right
Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin
Paul Hutson
Gynecologic Oncology, 2009
View PDFchevron_right
Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator
Hélène Bertrand
Oncotarget, 2019
View PDFchevron_right
Clinical management of oxaliplatin-associated neurotoxicity
A. Grothey
Clinical colorectal cancer, 2005
View PDFchevron_right
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Alice Gibson
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat
David Balayssac , Nicolas Authier , François Coudore
Toxicology, 2007
View PDFchevron_right
Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat
A. Eschalier
Pain, 2007
View PDFchevron_right
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
valentina carozzi
Molecular Pain, 2011
View PDFchevron_right
Cytoprotective Effect of Acetyl-l-Carnitine Evidenced by Analysis of Gene Expression in the Rat Brain
Rossana Scuri
Molecular Neurobiology, 2009
View PDFchevron_right
Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
Siu-fun Wong
2013
View PDFchevron_right
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
Alessandra Pacini
Neurotherapeutics, 2020
View PDFchevron_right
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels
B. Lapied
Journal of …, 2001
View PDFchevron_right
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Junichi Sakamoto
Cancer Chemotherapy and Pharmacology, 2013
View PDFchevron_right
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity
Pietro Ghezzi
Clinical cancer research : an official journal of the American Association for Cancer Research, 2006
View PDFchevron_right
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
Anastasia Tsingotjidou
Clinical Cancer Research, 2004
View PDFchevron_right